SINGLE AND MULTIPLE-DOSE SAFETY, PHARMACODYNAMICS AND PHARMACOKINETICS OF XANOMELINE, A NOVEL MUSCARINIC M1 AGONIST IN HEALTHY MALE-SUBJECTS

被引：0
|
作者：
BODICK, NC
SATTERWHITE, JH
LUCAS, RA
HEATON, J
CARTER, GV
机构：
[1] ELI LILLY & CO,LILLY LAB CLIN RES,INDIANAPOLIS,IN 46202
[2] LILLY RES CTR LTD,WINDLESHAM GU20 6PH,SURREY,ENGLAND
来源：
NEUROBIOLOGY OF AGING | 1994年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：S104 / S105
页数：2
相关论文
共 50 条
  • [1] SAFETY, TOLERANCE, AND PHARMACOKINETICS OF XANOMELINE TARTRATE, A NOVEL MUSCARINIC M1 AGONIST IN HEALTHY ELDERLY SUBJECTS
    SATTERWHITE, JH
    LUCAS, RA
    HEATON, J
    CARTER, GV
    [J]. NEUROBIOLOGY OF AGING, 1994, 15 : S104 - S104
  • [2] MULTIPLE-DOSE PHARMACOKINETICS OF TOPIRAMATE IN HEALTHY MALE-SUBJECTS
    DOOSE, DR
    SCOTT, VV
    MARGUL, BL
    MARRIOTT, TB
    NAYAK, RK
    [J]. EPILEPSIA, 1988, 29 (05) : 662 - 662
  • [3] Single- and multiple-dose pharmacokinetics, pharmacodynamics, and safety of apixaban in healthy Chinese subjects
    Cui, Yimin
    Song, Yan
    Wang, Jessie
    Yu, Zhigang
    Schuster, Alan
    Barrett, Yu Chen
    Frost, Charles
    [J]. CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2013, 5 : 177 - 184
  • [4] Multiple-dose pharmacokinetics, pharmacodynamics, and safety of taranabant, a novel selective cannabinoid-1 receptor inverse agonist, in healthy male volunteers
    Addy, Carol
    Rothenberg, Paul
    Li, Susie
    Majumdar, Anup
    Agrawal, Nancy
    Li, Hankun
    Zhong, Ling
    Yuan, Finyu
    Maes, Andrea
    Dunbar, Stephanie
    Cote, Losee
    Rosko, Kim
    Van Dyck, Kristien
    De Lepeleire, Inge
    de Hoon, Jan
    Van Hecken, Anne
    Depre, Marleen
    Knops, Annemie
    Gottesdiener, Keith
    Stoch, Aubrey
    Wagner, John
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 48 (06): : 734 - 744
  • [5] Multiple-Dose Pharmacokinetics, Pharmacodynamics, and Safety of the Urotensin-II Receptor Antagonist Palosuran in Healthy Male Subjects
    Sidharta, Patricia N.
    van Giersbergen, Paul L. M.
    Dingemanse, Jasper
    [J]. PHARMACOLOGY, 2018, 102 (5-6) : 339 - 346
  • [6] Pharmacokinetics, Pharmacodynamics and Safety of a Single Dose of Imarikiren, a Novel Renin Inhibitor, in Healthy Male Subjects
    Matsuno, Kumi
    Kuroda, Shingo
    Tanaka, Shingo
    Nakamichi, Hiroyuki
    Kagawa, Tomoya
    Koumura, Emiko
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 (05) : 607 - 614
  • [7] Multiple-dose pharmacokinetics, pharmacodynamics, safety, and tolerability of the orexin receptor antagonist almorexant in healthy subjects
    Hoever, P.
    de Haas, S.
    Chiossi, E.
    van Gerven, J.
    Dingemanse, J.
    [J]. SLEEP, 2008, 31 : A38 - A38
  • [8] Single- and multiple-dose escalation study to assess pharmacokinetics, pharmacodynamics and safety of oral esaxerenone in healthy Japanese subjects
    Kato, Manabu
    Furuie, Hidetoshi
    Shimizu, Takako
    Miyazaki, Atsuhiro
    Kobayashi, Fumiaki
    Ishizuka, Hitoshi
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 84 (08) : 1821 - 1829
  • [9] Multiple-dose safety and pharmacokinetics of oral garenoxacin in healthy subjects
    Gajjar, DA
    Bello, A
    Ge, Z
    Christopher, L
    Grasela, DM
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (07) : 2256 - 2263
  • [10] Pharmacokinetics, pharmacodynamics, and tolerance of single- and multiple-dose fexofenadine hydrochloride in healthy male volunteers
    Russell, T
    Stoltz, M
    Weir, S
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 64 (06) : 612 - 621
12345